VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DHRDanaher Corporation
$225.77$158.7B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
DHR logo

Danaher Corporation

DHR
NYSE · Life Science Tools
$225.77
At close - Nov 17, 4:00 PM EST - USD
Market Cap$158.71B
P/E36.8x
52W High$242.80
Volume3.56M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Bioprocessing Recovery Offsets Leverage And Goodwill Risks

Danaher's revenue growth inflected from -0.9% in 2025Q1 to 8.3% in 2026Q3 as bioprocessing destocking eased, with operating margin recovering to 19.0% from 16.5% in 2024Q3, suggesting the Life Sciences portfolio is normalizing though durability of end-demand warrants monitoring.

GrowthAccelerating
ProfitabilityModerate
ValuationReview
TechnicalsHealthy
Explore valuation models
MARKET ACTION

DHR price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

11/12 Beats

EPS beat 11 of last 12 quarters

02

Valuation risk

+7% Peers

P/E is 7% above peer median

03

Market leadership

RS 77 · Avg

Average momentum (RS Rating: 77)

04

Healthy Uptrend

Uptrend

Price > 50DMA > 200DMA

Next CatalystEstimated earnings · Jan 21
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth accelerated to 8.3% in 2026Q3 with gross margin at 58.5% and operating margin at 19.0%, indicating incomplete but genuine operating leverage as SG&A discipline offsets a rising $433M R&D line.

Analyst Consensus+5.8% target
Buy(43 analysts)
31 Buy11 Hold1 Sell

The Bull Case

Upside Catalysts

Life sciences leadership

Danaher is a leading global innovator in life sciences and diagnostics, committed to improving human health through science and technology.

Bioprocessing recovery momentum

The company has shown strong bioprocessing recovery, contributing to a 14.14% stock price appreciation since previous coverage.

Conservative guidance upside

Management's conservative 2026 guidance sets a baseline that could be exceeded, with projected high-single-digit EPS growth and 3-6% core revenue growth.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
DHR-1.49%
S&P 500 (^GSPC)+7.21%
1-Year Return
DHR+3.11%
S&P 500 (^GSPC)+10.03%
3-Year Return
DHR+10.49%
S&P 500 (^GSPC)+60.69%
5-Year Return
DHR-15.70%
S&P 500 (^GSPC)+52.07%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/EMedian
36.8x
Forward P/EExpansion
26.3x
EV/EBITDA60th %ile
24.1x
FCF YieldCash Flow
3.6%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
36.8x
36.3x
60th· Fair
EV/EBITDA
24.1x
23.3x
60th· Fair
Price/FCF
27.7x
30.4x
20th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$106.78-52.7%
Base (Fair)$206.79-11.3%
Bull$329.55+46.0%
$106.78 Bear$206.79 Base$329.55 Bull
Current Market Price: $225.77
Trades at a 9.2% premium to Base DCF ($206.79)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$24.57B+2.9% YoY
Net income FY25
$3.61B-7.3% YoY
Free cash flow FY25
$5.26B-0.7% YoY
Operating margin FY25
20.9%-0.8 pts YoY
ROIC (FY25)5.9%
Avg ROIC 5Y7.3%
ROE (TTM)8.2%
Piotroski Score7 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate11/12 (92%)
Revenue Beat Rate9/12 (75%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 21, 2026
$2.11+9.9%
vs $1.92
$6.6B-0.1%
vs $6.6B
Q3 2026
Jul 21, 2026
$1.94+4.9%
vs $1.85
$6.3B+2.4%
vs $6.1B
Q2 2026
Apr 21, 2026
$2.06+6.2%
vs $1.94
$6.0B-0.5%
vs $6.0B
Q1 2026
Jan 28, 2026
$2.23+3.2%
vs $2.16
$6.8B+0.4%
vs $6.8B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Defense World·1d ago
Danaher Corporation $DHR Shares Bought by BCS Private Wealth Management Inc.

BCS Private Wealth Management Inc. lifted its position in Danaher Corporation (NYSE: DHR) by 27.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,177 shares of the conglomerate's stock after buying an additional 2,800 shares during the quarter. BCS Private

Seeking Alpha·1d ago
Danaher Corporation (DHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Danaher Corporation (DHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Defense World·6d ago
CenterBook Partners LP Purchases 2,610 Shares of Danaher Corporation $DHR

CenterBook Partners LP purchased a new stake in Danaher Corporation (NYSE: DHR) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 2,610 shares of the conglomerate's stock, valued at approximately $578,000. Other hedge funds and other institutional investors also recently

Zacks Investment Research·Nov 10, 2026
VTRS or DHR: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two stocks presents investors with the better value opportunity right now?

Filtered for Danaher CorporationMore Headlines
04

Compare before deciding

Benchmark DHR against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Danaher Corporation (DHR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
DHR logoDHRDanaher CorporationCurrent
$225.77$158.71B36.842.9%16.91%8.18%0.55%
TMO logoTMOThermo Fisher Scientific Inc.
$686.79$255.23B35.973.91%14.96%13.3%0.25%
A logoAAgilent Technologies, Inc.
$172.19$48.63B33.846.73%19.53%20.47%0.58%
WAT logoWATWaters Corporation
$449.78$33.64B451.776.99%1.75%0.81%—
BIO logoBIOBio-Rad Laboratories, Inc.
$358.19$9.64B9.440.65%39.45%14.07%—
BRKR logoBRKRBruker Corporation
$61.36$9.34B-75.832.08%-3.51%-5.05%0.24%

Compare DHR vs Peers

Danaher Corporation (DHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TMO

Most directly comparable listed peer for DHR.

Scale Benchmark

vs ABT

Larger-name benchmark to compare DHR against a more recognizable public peer.

Peer Set

Compare Top 5

vs TMO, A, WAT, BIO

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

DHR SEC Filings & Documents

Danaher Corporation (DHR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 21, 2026·SEC

Material company update

Oct 13, 2026·SEC

Material company update

Aug 3, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 20, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Oct 21, 2026·SEC

FY 2026

Jul 21, 2026·SEC

FY 2026

Apr 21, 2026·SEC

Get notified when DHR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

DHR Frequently Asked Questions

Danaher Corporation (DHR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Danaher Corporation's revenue?

Danaher Corporation (DHR) reported $25.61B in revenue over the trailing twelve months. Revenue was $24.57B in fiscal year 2025. That is 1256% more than the $1.81B of fiscal year 1996.

How fast is Danaher Corporation growing?

Danaher Corporation (DHR) grew revenue by 5.5% over the trailing twelve months, compared with the twelve months before.

Is DHR profitable?

Yes. Danaher Corporation (DHR) earned $4.33B in net income over the trailing twelve months (a 16.9% net margin).

Dividend & Returns
Does DHR pay dividends?

Yes. Danaher Corporation (DHR) pays a dividend that yields 0.55% at the current price, a small yield.

What is DHR's return on equity?

Danaher Corporation (DHR) had a return on equity (ROE) of 8.2% over the trailing twelve months. That is below the market's typical 10-15%.

What is Danaher Corporation's free cash flow?

Danaher Corporation (DHR) generated $5.73B in free cash flow over the trailing twelve months.

What if you invested $1,000 in DHR back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →